Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ArcelorMittal stock logo
MT
ArcelorMittal
$60.52
-3.6%
$65.96
$38.67
▼
$79.68
$49.82B1.551.44 million shs988,449 shs
Viatris Inc. stock logo
VTRS
Viatris
$20.74
-0.4%
$18.18
$10.15
▼
$21.20
$23.70B0.899.70 million shs7.14 million shs
Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ArcelorMittal stock logo
MT
ArcelorMittal
-3.63%-5.72%-3.91%-15.95%+53.37%
Viatris Inc. stock logo
VTRS
Viatris
-0.38%+1.22%+11.15%+28.26%+93.47%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ArcelorMittal stock logo
MT
ArcelorMittal
$60.52
-3.6%
$65.96
$38.67
▼
$79.68
$49.82B1.551.44 million shs988,449 shs
Viatris Inc. stock logo
VTRS
Viatris
$20.74
-0.4%
$18.18
$10.15
▼
$21.20
$23.70B0.899.70 million shs7.14 million shs
Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ArcelorMittal stock logo
MT
ArcelorMittal
-3.63%-5.72%-3.91%-15.95%+53.37%
Viatris Inc. stock logo
VTRS
Viatris
-0.38%+1.22%+11.15%+28.26%+93.47%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ArcelorMittal stock logo
MT
ArcelorMittal
2.53
Moderate Buy$74.5523.19% Upside
Viatris Inc. stock logo
VTRS
Viatris
2.60
Moderate Buy$21.443.40% Upside

Current Analyst Ratings Breakdown

Latest VTRS and MT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/16/2026
Viatris Inc. stock logo
VTRS
Viatris
Boost Price TargetOverweight$22.00 ➝ $25.00
11/13/2026
ArcelorMittal stock logo
MT
ArcelorMittal
UpgradeHold (C) ➝ Hold (C+)
11/9/2026
Viatris Inc. stock logo
VTRS
Viatris
DowngradeHold (C) ➝ Sell (D)
11/6/2026
Viatris Inc. stock logo
VTRS
Viatris
Reiterated RatingBuy$22.00
11/6/2026
Viatris Inc. stock logo
VTRS
Viatris
Boost Price TargetNeutral$20.00 ➝ $21.00
10/29/2026
ArcelorMittal stock logo
MT
ArcelorMittal
DowngradeHold (C+) ➝ Hold (C)
10/26/2026
Viatris Inc. stock logo
VTRS
Viatris
Boost Price TargetNeutral$13.00 ➝ $14.00
10/21/2026
Viatris Inc. stock logo
VTRS
Viatris
Boost Price TargetNeutral$18.00 ➝ $20.00
10/15/2026
ArcelorMittal stock logo
MT
ArcelorMittal
UpgradeNeutral ➝ Overweight
10/14/2026
ArcelorMittal stock logo
MT
ArcelorMittal
UpgradeHold (C) ➝ Hold (C+)
10/14/2026
Viatris Inc. stock logo
VTRS
Viatris
UpgradeSell (D+) ➝ Hold (C)
(Data available from 11/17/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ArcelorMittal stock logo
MT
ArcelorMittal
$61.35B0.76$7.14 per share8.47$72.32 per share0.84
Viatris Inc. stock logo
VTRS
Viatris
$14.30B1.66$7.41 per share2.80$11.94 per share1.74
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ArcelorMittal stock logo
MT
ArcelorMittal
$3.15B$1.3517.618.660.781.64%4.89%2.82%2/4/2027 (Estimated)
Viatris Inc. stock logo
VTRS
Viatris
-$3.51B-$0.53N/A7.512.22-4.13%20.82%8.30%N/A

Latest VTRS and MT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/5/2026Q3 2026
ArcelorMittal stock logo
MT
ArcelorMittal
$0.80$1.15+$0.35-$0.52$17.77 billion$16.47 billion
11/5/2026Q3 2026
Viatris Inc. stock logo
VTRS
Viatris
$0.6370$0.71+$0.0730-$0.28$3.79 billion$3.75 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
ArcelorMittal stock logo
MT
ArcelorMittal
$0.510.84%N/A37.78%N/A
Viatris Inc. stock logo
VTRS
Viatris
$0.482.31%N/AN/A N/A

Latest VTRS and MT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
11/2/2026
Viatris Inc. stock logo
VTRS
Viatris
quarterly$0.122.5%11/23/202611/23/202612/16/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ArcelorMittal stock logo
MT
ArcelorMittal
0.21
1.41
0.53
Viatris Inc. stock logo
VTRS
Viatris
0.85
1.55
0.97

Institutional Ownership

CompanyInstitutional Ownership
ArcelorMittal stock logo
MT
ArcelorMittal
9.29%
Viatris Inc. stock logo
VTRS
Viatris
79.88%

Insider Ownership

CompanyInsider Ownership
ArcelorMittal stock logo
MT
ArcelorMittal
0.06%
Viatris Inc. stock logo
VTRS
Viatris
0.28%
CompanyEmployeesShares OutstandingFree FloatOptionable
ArcelorMittal stock logo
MT
ArcelorMittal
125,554775.00 million774.54 millionOptionable
Viatris Inc. stock logo
VTRS
Viatris
30,0001.15 billion1.14 billionOptionable

Recent News About These Companies

Viatris to Participate in Upcoming Investor Conferences
Viatris (VTRS) Stock Forecast & Price Target
Viatris Inc. (VTRS) Q3 2026 Earnings Call Transcript
Viatris Inc. Q3 Earnings Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ArcelorMittal stock logo

ArcelorMittal NYSE:MT

$60.52 -2.27 (-3.62%)
Closing price 11/16/2026 03:59 PM Eastern
Extended Trading
$61.28 +0.76 (+1.26%)
As of 08:10 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ArcelorMittal S.A., together with its subsidiaries, operates as integrated steel and mining companies in the United States, Europe, and internationally. It offers semi-finished flat products, including slabs; finished flat products comprising plates, hot- and cold-rolled coils and sheets, hot-dipped and electro-galvanized coils and sheets, tinplate, and color coated coils and sheets; semi-finished long products, such as blooms and billets; finished long products consisting of bars, wire-rods, structural sections, rails, sheet piles, and wire-products; and seamless and welded pipes and tubes. The company also provides mining products, such as iron ore lumps, fines, concentrates, pellets, and sinter feeds; and coking coal. It sells its products to various customers in the automotive, appliance, engineering, construction, energy, and machinery industries through a centralized marketing organization, as well as distributors. The company has iron ore mining activities in Brazil, Bosnia, Canada, Liberia, Mexico, South Africa, and Ukraine. ArcelorMittal S.A. was founded in 1976 and is headquartered in Luxembourg City, Luxembourg.

Viatris stock logo

Viatris NASDAQ:VTRS

$20.74 -0.08 (-0.38%)
Closing price 11/16/2026 04:00 PM Eastern
Extended Trading
$20.67 -0.07 (-0.34%)
As of 08:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides it medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as glargine and SEMGLEE names. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; and Momenta Pharmaceuticals, Inc. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.